Precise regulation of inflammation and immunosuppressive microenvironment for amplified photothermal/immunotherapy against tumour recurrence and metastasis
Source abstract
Abstract
Inflammation is a beneficial response of the body in response to external stimuli, while the overwhelming inflammation caused by disease therapy often leads to treatment failure. Therefore, precise regulation of inflammation is essential in remodelling body microenvironment and enhancing the therapy efficiency. Herein, we show an efficient strategy for precisely regulating inflammation and immunosuppressive microenvironment after photothermal therapy (PTT) by controlling release of dietary luteolin through dynamical disassembly of photothermal agent, which dramatically increase the therapy efficiency of PTT and accompanied immunotherapy. As a result, not only the local tumour could be effectively destructed by PTT, but also the combination of PTT-induced immunogenic death (ICD), and regulation of inflammation after PTT and immunosuppressive tumour microenvironment by released luteolin could achieve the effective inhibition of tumour recurrence and metastasis. As a proof of concept, this research demonstrates how to solve tumour recurrence and metastasis by precise regulation of inflammation inherited in cancer therapy. (c) 2021 Elsevier Ltd. All rights reserved.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (67)
Show source-provided references
1. Inflammation10.1038/454427a ↗
2. Origin and physiological roles of inflammation10.1038/nature07201 ↗
3. Cyclodextrin-derived intrinsically bioactive nanoparticles for treatment of acute and chronic inflammatory diseases10.1002/adma.201904607 ↗
4. Inflammation-a new therapeutic target in pneumonia10.1159/000084039 ↗
5. Calming cytokine storm in pneumonia by targeted delivery of TPCA-1 using platelet-derived extracellular vesicles10.1016/j.matt.2020.05.017 ↗
6. Cytokine storm intervention in the early stages of COVID-19 pneumonia10.1016/j.cytogfr.2020.04.002 ↗
7. Inflammation intersection: gp130 balances gut irritation and stomach cancer10.1038/nm1002-1080 ↗
8. NF-κB and STAT3-key players in liver inflammation and cancer10.1038/cr.2010.183 ↗
9. Inflammation mediated metastasis: immune induced epithelial-to-mesenchymal transition in inflammatory breast cancer cells10.1371/journal.pone.0132710 ↗
10. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer
11. Unveiling the link between inflammation and adaptive immunity in breast cancer10.3389/fimmu.2019.00056 ↗
12. Acute inflammation induces immunomodulatory effects on myeloid cells associated with anti-tumor responses in a tumor mouse model10.1016/j.jare.2015.06.001 ↗
13. A cytokine-mediated link between innate immunity, inflammation, and cancer10.1172/JCI31537 ↗
14. Inflammation and cancer: triggers, mechanisms, and consequences10.1016/j.immuni.2019.06.025 ↗
15. Multispecific platinum (IV) complex deters breast cancer via interposing inflammation and immunosuppression as an inhibitor of COX-2 and PD-L110.1002/anie.202011273 ↗
16. Immunity, inflammation, and cancer10.1016/j.cell.2010.01.025 ↗
17. Immunity, inflammation, and cancer: an eternal fight between good and evil10.1172/JCI80007 ↗
18. Anti-inflammatory catecholic chitosan hydrogel for rapid surgical trauma healing and subsequent prevention of tumor recurrence10.1016/j.cclet.2020.02.032 ↗
19. A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy10.1002/lsm.22934 ↗
20. Systemic effects of ionizing radiation at the proteome and metabolome levels in the blood of cancer patients treated with radiotherapy: the influence of inflammation and radiation toxicity10.1080/09553002.2017.1304590 ↗
21. Organic/polymer photothermal nanoagents for photoacoustic imaging and photothermal therapy in vivo10.1007/s40843-019-9470-3 ↗
22. Sequential PDT and PTT using dual‐modal single‐walled carbon nanohorns synergistically promote systemic immune responses against tumor metastasis and relapse10.1002/advs.202001088 ↗
23. Intracellularly generated immunological gold nanoparticles for combinatorial photothermal therapy and immunotherapy against tumor10.1021/acs.nanolett.9b02903 ↗
24. Second near-infrared photothermal semiconducting polymer nanoadjuvant for enhanced cancer immunotherapy
25. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy10.1038/s41467-019-13204-3 ↗
26. Transforming weakness into strength: photothermal-therapy induced inflammation enhanced cytopharmaceutical chemotherapy as a combination anticancer treatment
27. A disassembling strategy overcomes the EPR effect and renal clearance dilemma of the multifunctional theranostic nanoparticles for cancer therapy10.1016/j.biomaterials.2019.01.025 ↗
28. Multifunctional theranostic nanoparticles derived from fruit-extracted anthocyanins with dynamic disassembly and elimination abilities10.1021/acsnano.8b03525 ↗
29. A review on role of essential trace elements in health and disease10.4103/2277-8632.158577 ↗
30. Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies10.1016/j.jep.2018.05.019 ↗
31. Luteolin, a flavonoid with potential for cancer prevention and therapy10.2174/156800908786241050 ↗
32. Electrochemical sensor for facile detection of trace luteolin based on thio-β-cyclodextrin functionalized graphene/gold nanoparticles hybrids10.1016/j.jelechem.2015.11.005 ↗
33. Distribution and biological activities of the flavonoid luteolin10.2174/138955709787001712 ↗
34. Final report on the safety assessment of polyvinylpyrrolidone (PVP)10.1177/109158189801700408 ↗
35. Nanoparticle therapeutics: an emerging treatment modality for cancer10.1038/nrd2614 ↗
36. Long-circulating poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles with modulated surface charge10.1016/S0168-3659(01)00451-5 ↗
37. Exploration of FeIII-phenol complexes for photothermal therapy and photoacoustic imaging10.1021/acsbiomaterials.9b00711 ↗
38. Surface-confined amorphous films from metal-coordinated simple penolic ligands10.1021/acs.chemmater.5b02790 ↗
39. Engineering metal–organic frameworks for photoacoustic imaging-guided chemo-/photothermal combinational tumor therapy10.1021/acsami.8b13492 ↗
40. Simultaneous application of photothermal therapy and an anti-inflammatory prodrug using pyrene-aspirin-loaded gold nanorod graphitic nanocapsules10.1002/anie.201709648 ↗
41. Multifunctional carbon-silica nanocapsules with gold core for synergistic photothermal and chemo-cancer therapy under the guidance of bimodal imaging10.1002/adfm.201600985 ↗
42. Multimodal imaging-guided antitumor photothermal therapy and drug delivery using bismuth selenide spherical sponge10.1021/acsnano.6b05427 ↗
43. Beyond the roles in biomimetic chemistry: an insight into the intrinsic catalytic activity of an enzyme for tumor-selective phototheranostics10.1021/acsnano.8b05797 ↗
44. Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA10.1080/10915810290096522 ↗
45. Rational design of a prodrug to inhibit self-inflammation for cancer treatment10.1039/D1NR00132A ↗
46. An anti-inflammatory nanoagent for tumor-targeted photothermal therapy10.1039/C9CC04486H ↗
47. Near-infrared light responsive nanoreactor for simultaneous tumor photothermal therapy and carbon monoxide-mediated anti-inflammation10.1021/acscentsci.9b01342 ↗
48. Engineering nanoparticles to locally activate T cells in the tumor microenvironment10.1126/sciimmunol.aau6584 ↗
49. Making sense of inflammation, epigenetics, and memory CD8+ T-cell differentiation in the context of infection10.1111/j.0105-2896.2006.00399.x ↗
50. Molecular and cellular insights into T cell exhaustion10.1038/nri3862 ↗
51. Cyclooxygenase-dependent tumor growth through evasion of immunity10.1016/j.cell.2015.08.015 ↗
52. The role of prostaglandin E2 in tumor-associated immunosuppression10.1016/j.molmed.2015.11.003 ↗
53. GSH depletion liposome adjuvant for augmenting the photothermal immunotherapy of breast cancer10.1126/sciadv.abc4373 ↗
54. Near-infrared-triggered photodynamic therapy with multitasking upconversion nanoparticles in combination with checkpoint blockade for immunotherapy of colorectal cancer10.1021/acsnano.7b00715 ↗
55. Immunogenic cell death and DAMPs in cancer therapy10.1038/nrc3380 ↗
56. Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases10.1016/j.biomaterials.2018.05.051 ↗
57. Polyphenol-based nanomedicine evokes immune activation for combination cancer treatment
58. Tumor-activated size-enlargeable bioinspired lipoproteins access cancer cells in tumor to elicit anti-tumor immune responses
59. Near-infrared II phototherapy induces deep tissue immunogenic cell death and potentiates cancer immunotherapy10.1021/acsnano.9b06040 ↗
60. COX-2 expression positively correlates with PD-L1 expression in human melanoma cells10.1186/s12967-017-1150-7 ↗
61. Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells10.1023/B:MCBI.0000044364.73144.fe ↗
62. Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: involvement of iNOS and COX-210.4103/0973-1296.133285 ↗
63. Targeting metastasis10.1038/nrc.2016.25 ↗
64. Treating metastatic cancer with nanotechnology10.1038/nrc3180 ↗
65. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy10.1038/ncomms13193 ↗
66. Consensus guidelines for the detection of immunogenic cell death10.4161/21624011.2014.955691 ↗
67. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape10.1186/s12943-018-0928-4 ↗